PRKDC and cancer: DNA-PKcs is a core mediator of the non-homologous end joining pathway, which functions to repair DNA double-strand breaks.Post-translational modifications and protein–protein interactions regulate DNA-PKcs activity.DNA-PKcs inhibition has been widely associated with restoring radio- and chemo-sensitivity in a range of cancers.DNA-PKcs inhibitors developed to date are largely unsuitable for clinical use.